Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Pickart, L., Vasquez-Soltero, J., & Margolina, A
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Time zone changes may affect the weekly dosing schedule, and patients should plan how to maintain consistent seven-day intervals between doses while accommodating their travel schedule
Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats
US$ 25.03
US$ 23.54
US$ 28.90
US$ 29.33
US$ 24.69
US$ 29.29
US$ 26.41
US$ 20.83
